Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational ...
RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Merakris Therapeutics announced that it will present encouraging safety and efficacy data from the first of a two-part Phase 2
Source: eagletribune.com